Judith J Prochaska1, Sebastien C Fromont2, Danielle E Ramo2, Kelly C Young-Wolff3, Kevin Delucchi2, Richard A Brown4, Sharon M Hall2. 1. Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA; jpro@stanford.edu. 2. Department of Psychiatry, University of California, San Francisco, San Francisco, CA; 3. Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA; 4. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI.
Abstract
INTRODUCTION: Treatment of tobacco use in mental health settings is rare despite high rates of comorbidity. With a focus on early intervention, we evaluated a tobacco treatment intervention among adolescents and young adults recruited from outpatient, school-based, and residential mental health settings and tested for gender differences. METHODS: Intervention participants received computerized motivational feedback at baseline, 3 months, and 6 months and were offered 12 weeks of cessation counseling and nicotine patches. Usual care participants received a self-help guide and brief cessation advice. We examined 7-day point prevalence abstinence with biochemical confirmation at 3, 6, and 12 months; smoking reduction; and 24-hr quit attempts. RESULTS: At baseline, the sample (N = 60, 52% female, mean age = 19.5±2.9 years, 40% non-Hispanic Caucasian) averaged 7±6 cigarettes/day, 62% smoked daily, 38% smoked ≤ 30 min of waking, 12% intended to quit in the next month, 47% had a parent who smoked, and 3 of 5 of participants' closest friends smoked on average. During the 12-month study, 47% of the sample reduced their smoking, 80% quit for 24 hr, and 11%, 13%, and 17% confirmed 7-day point prevalence abstinence at 3-, 6-, and 12-month follow-up, respectively, with no differences by treatment condition (ps > .400). Over time, abstinence was greater among girls (adjusted odds ratio [AOR] = 8.9) than among boys, and abstinence was greater for lighter smokers than heavier smokers (AOR = 4.5) (p < .05). No mental health or other measured variables predicted abstinence. CONCLUSIONS:Adolescent and young adult smokers with mental health concerns are a challenging group to engage and to effectively treat for tobacco addiction, particularly heavier smokers and boys. Innovative approaches are needed.
RCT Entities:
INTRODUCTION: Treatment of tobacco use in mental health settings is rare despite high rates of comorbidity. With a focus on early intervention, we evaluated a tobacco treatment intervention among adolescents and young adults recruited from outpatient, school-based, and residential mental health settings and tested for gender differences. METHODS: Intervention participants received computerized motivational feedback at baseline, 3 months, and 6 months and were offered 12 weeks of cessation counseling and nicotine patches. Usual care participants received a self-help guide and brief cessation advice. We examined 7-day point prevalence abstinence with biochemical confirmation at 3, 6, and 12 months; smoking reduction; and 24-hr quit attempts. RESULTS: At baseline, the sample (N = 60, 52% female, mean age = 19.5±2.9 years, 40% non-Hispanic Caucasian) averaged 7±6 cigarettes/day, 62% smoked daily, 38% smoked ≤ 30 min of waking, 12% intended to quit in the next month, 47% had a parent who smoked, and 3 of 5 of participants' closest friends smoked on average. During the 12-month study, 47% of the sample reduced their smoking, 80% quit for 24 hr, and 11%, 13%, and 17% confirmed 7-day point prevalence abstinence at 3-, 6-, and 12-month follow-up, respectively, with no differences by treatment condition (ps > .400). Over time, abstinence was greater among girls (adjusted odds ratio [AOR] = 8.9) than among boys, and abstinence was greater for lighter smokers than heavier smokers (AOR = 4.5) (p < .05). No mental health or other measured variables predicted abstinence. CONCLUSIONS: Adolescent and young adult smokers with mental health concerns are a challenging group to engage and to effectively treat for tobacco addiction, particularly heavier smokers and boys. Innovative approaches are needed.
Authors: Thomas M Piasecki; Douglas E Jorenby; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: Exp Clin Psychopharmacol Date: 2003-11 Impact factor: 3.157
Authors: Sharon M Hall; Janice Y Tsoh; Judith J Prochaska; Stuart Eisendrath; Joseph S Rossi; Colleen A Redding; Amy B Rosen; Marc Meisner; Gary L Humfleet; Julie A Gorecki Journal: Am J Public Health Date: 2006-10 Impact factor: 9.308
Authors: R A Brown; S E Ramsey; D R Strong; M G Myers; C W Kahler; C W Lejuez; R Niaura; U E Pallonen; A N Kazura; M G Goldstein; D B Abrams Journal: Tob Control Date: 2003-12 Impact factor: 7.552
Authors: Erin A Vogel; Johannes Thrul; Gary L Humfleet; Kevin L Delucchi; Danielle E Ramo Journal: Health Psychol Date: 2018-11-29 Impact factor: 4.267
Authors: Mary F Brunette; Joelle C Ferron; Kelly A Aschbrenner; Sarah I Pratt; Pamela Geiger; Samuel Kosydar Journal: Addict Behav Date: 2018-09-25 Impact factor: 3.913
Authors: Mary F Brunette; Joelle C Ferron; Delbert Robinson; Daniel Coletti; Pamela Geiger; Timothy Devitt; Vanessa Klodnick; Jennifer Gottlieb; Haiyi Xie; Mary Ann Greene; Douglas Ziedonis; Robert E Drake; Gregory J McHugo Journal: Nicotine Tob Res Date: 2018-09-04 Impact factor: 4.244
Authors: Andrea C Villanti; Julia C West; Elias M Klemperer; Amanda L Graham; Darren Mays; Robin J Mermelstein; Stephen T Higgins Journal: Am J Prev Med Date: 2020-05-14 Impact factor: 5.043
Authors: Thomas R Fanshawe; William Halliwell; Nicola Lindson; Paul Aveyard; Jonathan Livingstone-Banks; Jamie Hartmann-Boyce Journal: Cochrane Database Syst Rev Date: 2017-11-17
Authors: Minda A Gowarty; Meghan R Longacre; Roger Vilardaga; Nathan J Kung; Ashley E Gaughan-Maher; Mary F Brunette Journal: JMIR Ment Health Date: 2021-07-07